1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Hearing Implants Overview

3 Products under Development
3.1 Hearing Implants - Pipeline Products by Stage of Development
3.2 Hearing Implants - Pipeline Products by Segment
3.3 Hearing Implants - Pipeline Products by Territory
3.4 Hearing Implants - Pipeline Products by Regulatory Path
3.5 Hearing Implants - Pipeline Products by Estimated Approval Date
3.6 Hearing Implants - Ongoing Clinical Trials

4 Hearing Implants - Pipeline Products under Development by Companies
4.1 Hearing Implants Companies - Pipeline Products by Stage of Development
4.2 Hearing Implants - Pipeline Products by Stage of Development

5 Hearing Implants Companies and Product Overview
5.1 Advanced Bionics LLC Company Overview
5.1.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Auritec Pharmaceuticals Inc Company Overview
5.2.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Ceragenix Pharmaceuticals, Inc. (Ictive) Company Overview
5.3.1 Ceragenix Pharmaceuticals, Inc. (Ictive) Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cochlear Ltd Company Overview
5.4.1 Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Demant A/S Company Overview
5.5.1 Demant A/S Pipeline Products & Ongoing Clinical Trials Overview
5.6 Ecole Polytechnique Federale de Lausanne Company Overview
5.6.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
5.7 Envoy Medical Corp Company Overview
5.7.1 Envoy Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 Hannover Medical School Company Overview
5.8.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
5.9 Hemidei Solution Company Overview
5.9.1 Hemidei Solution Pipeline Products & Ongoing Clinical Trials Overview
5.10 Huntington Medical Research Institutes Company Overview
5.10.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview
5.11 iotaMotion Inc Company Overview
5.11.1 iotaMotion Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Labyrinth Devices Company Overview
5.12.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview
5.13 MED-EL Elektromedizinische Gerate Gesellschaft mbH Company Overview
5.13.1 MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview
5.14 Northwestern University Company Overview
5.14.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.15 Oticon Medical AB Company Overview
5.15.1 Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview
5.16 OtoKinetics Inc Company Overview
5.16.1 OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Ototronix, LLC Company Overview
5.17.1 Ototronix, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.18 Sonova Holding AG Company Overview
5.18.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview
5.19 SpecialtyCare Inc Company Overview
5.19.1 SpecialtyCare Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Tel Aviv Sourasky Medical Center Company Overview
5.20.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.21 The University of Nottingham Company Overview
5.21.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
5.22 Trinity College Dublin Company Overview
5.22.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
5.23 University of Florida Company Overview
5.23.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.24 University of Michigan Pediatric Device Consortium Company Overview
5.24.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview
5.25 University of Oklahoma Company Overview
5.25.1 University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview
5.26 University of South Florida Company Overview
5.26.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.27 University of Utah Company Overview
5.27.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
5.28 University of Wisconsin Madison Company Overview
5.28.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

6 Hearing Implants- Recent Developments
6.1 Nov 02, 2020: Elos Medtech investing to meet increased demand in robotic surgery
6.2 Oct 19, 2020: University of Sydney research could lead to customised cochlear implants
6.3 Aug 06, 2020: Team to create customizable cochlear implant programming
6.4 Jun 26, 2020: VISE researchers receive $3.1M grant for customizable cochlear implant programming
6.5 May 19, 2020: Cochlear: Denial of appeal rehearing in US patent infringement case
6.6 Mar 19, 2020: Federal Circuit affirms Alfred E. Mann Foundation’s $268M win against Cochlear
6.7 Feb 24, 2020: Intersect ENT reports fourth quarter and full year 2019 results
6.8 Feb 18, 2020: AB initiates voluntary field corrective action – Strong performance of the Hearing Instruments business
6.9 Feb 18, 2020: Elos Medtech - Year-end report, 1 January - 31 December, 2019
6.10 Feb 18, 2020: AB initiates voluntary field corrective action – Strong performance of the Hearing Instruments business
6.11 Jan 16, 2020: Audax Private Debt provides fincing to support Olympus Partners Investment in Soliant Health
6.12 Jan 13, 2020: Intersect ENT reports prelimiry full year 2019 revenue
6.13 Jan 10, 2020: Sonova announces changes to its Board of Directors
6.14 Dec 12, 2019: Cochlear obtains FDA approval for bone conduction implant
6.15 Dec 11, 2019: FDA clears Cochlear’s innovative new Osia 2 hearing implant system
6.16 Dec 10, 2019: Appointment of Michael Daniell to the Cochlear Limited Board

7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer